Chong Zhang

Title: Innovations of Chong Zhang in Biotechnology

Introduction

Chong Zhang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of plant immune proteins. His work focuses on enhancing plant disease resistance and promoting growth through innovative methods.

Latest Patents

Chong Zhang holds a patent for a multivalent plant immune fusion protein, specifically the AB-NAC-189. This invention includes a method for producing the protein and its various applications. The AB-NAC-189 protein is a fusion of a polypeptide segment AB, a nascent polypeptide-associated complex (NAC), and a protein corresponding to amino acids 1-189 from the N-terminal of protein HarpinEa. This multivalent fusion protein effectively stimulates the hypersensitive response in tobacco leaves and exhibits good thermal stability. It not only enhances the immune response of plants but also improves their disease resistance and promotes growth. The AB-NAC-189 multivalent vaccine demonstrates higher activity per unit concentration and significantly promotes chlorophyll synthesis in Goji berries, thereby improving their yield and quality.

Career Highlights

Chong Zhang is associated with Suzhou Yishuimo Biological Technology Co., Ltd., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential impact on agricultural practices and plant health.

Collaborations

Chong Zhang collaborates with Aiyou Sun, contributing to advancements in their research and development efforts.

Conclusion

Chong Zhang's innovative work in biotechnology, particularly with the AB-NAC-189 protein, showcases his commitment to enhancing plant health and agricultural productivity. His contributions are paving the way for future advancements in the field.